Metrics is contract development and manufacturing organization that provides quality work to quality clients from quality people.
CoreRx, Inc. is a full service classical pharmaceutical development and consultation organization dedicated to bringing investigational, new, and abbreviated drug applications to the market.
Cirrus Pharmaceuticals, Inc. is a Contract Research Organization specializing in Strategic Product Development.
BioConvergence LLC is a contract services firm specializing in product development services including: analytical, process and formulation development for small and large molecules.
Azopharma Product Development Group provides comprehensive drug development services from discovery to commercialization.
ARL supports new drug development during the early stage of drug discovery and development .
Almac offers an extensive range of drug development services from biomarker discovery and validation; genomic services; chemical development and supply of API; pharmaceutical development, manufacture, preparation, distribution, and management of clinical supplies (including IVRS/EDC/ePRO); through to commercial manufacture and packaging of pharmaceutical product.
The Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy is pleased to announce the 2009 recipients of the Pittsburgh Conference Memorial National College Grants.
FEI’s Magellan extreme high-resolution scanning electron microscope (XHR SEM) allows scientists and engineers to see 3D surface images at many different angles.
ChemImage is set to help generic drug makers achieve bioequivalence for nasal spray suspensions and inhalation products by providing an accurate way to determine drug particle size distribution in a drug product.
Scientists at Karolinska Institutet in Sweden have shown that a previously unknown gene, Wrap53, controls the activity of the gene p53.
Compounds extracted from green vegetables such as broccoli and cabbage, when combined with selenium, could be a potent drug against melanoma, according to cancer researchers.
Top Wyeth executives will get multimillion-dollar cash payouts related to the pharmaceutical company's pending acquisition by Pfizer Inc., according to a regulatory filing.
Internal AstraZeneca reports and e-mails written by company officials show they knew a decade ago that their psychiatric drug Seroquel caused diabetes and major weight gain, said lawyers for plaintiffs suing the company.
As President Barack Obama's health secretary, Kansas Governor Kathleen Sebelius immediately will face a host of difficult policy issues including safety lapses at the FDA.